Neurofibromatosis type 1 (NF1) is a rare illness that results in the onset of tumours that, on occasion, become malignant and metastasise, compromising the survival of the patient. Peinado and his tea...
Read moreFrom today and until Wednesday, around 20 speakers from around the world and 150 participants will debate cutting-edge research into plasticity and cell migration—two key aspects in paediatric canc...
Read moreThe expression of a central regulator of cell metabolism, PGC1A is associated with prostate cancer aggressiveness. The research paves the way for the identification of patients at risk of developing m...
Read moreEste nuevo fármaco -Sym004- es un mix de anticuerpos, y se ha demostrado que funciona, tanto in vitro como in vivo, aunque haya mutaciones en los receptores y de manera más potente. Los resultados d...
Read moreIRB Barcelona group leader in the Oncology Programme talks about metastasis, challenges and Barcelona
Read moreThe finding is considered one of the most important advances for over a century in addressing the challenge of predicting where tumor metastases will occur
Read moreA study published in the Journal of National Cancer Institute (JNCI) by ICREA researcher Roger Gomis may be key to the early detection of patients at risk of developing metastasis to the bone. This ne...
Read moreThis June, Roger Gomis will start a study on a protein that confers tumour cells the capacity to colonise and to become resistant to treatment
Read moreThe study proves that human tumours change throughout their natural history by means of genome regulation (due to epigenetic changes) in order to adapt and survive in invaded tissues
Read moreThe next step in the group’s research will be explore these control mechanisms further and study how alterations in the mechanisms promote metastasis, with the ultimate goal of being able to redirec...
Read more